The CJC-1295 stack
Ipamorelin is widely sold paired with CJC-1295.
Why ipamorelin is almost always paired
Ipamorelin is widely sold paired with CJC-1295. FDA’s compounding review found pharmacies and clinics marketing the combination, including a combined vial, and quotes an expert calling it "trending"; no source this course cites tests the two compounds together. The idea behind the pairing does have a footing: in 1990, in normal men, a growth-hormone-releasing peptide and GHRH given together stimulated GH release synergistically, which the authors read as evidence that the two act independently.
Everything in this unit turns on how far that 1990 result carries. It used the prototype hexapeptide and native GHRH, not ipamorelin and not CJC-1295. This unit covers the pairing’s logic, the difference between the no-DAC and DAC versions of CJC-1295, why pulsatility is the argument people make, and how to read stack claims honestly.